RE: ASK1, a new target in treating cardiorenal syndrome (CRS)

Affiliations

• ¹ Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
• ² Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia.
• ³ Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia.
• ⁴ Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA.
• ⁵ Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: bing.wang@baker.edu.au.